Back to Search
Start Over
CSF1R Ligands Expressed by Murine Gliomas Promote M-MDSCs to Suppress CD8 + T Cells in a NOS-Dependent Manner.
- Source :
- Cancers; Sep2024, Vol. 16 Issue 17, p3055, 20p
- Publication Year :
- 2024
-
Abstract
- Simple Summary: Currently, there are no effective therapies for glioblastoma. Infiltrating myeloid cells contributes significantly to the immune suppressive tumor microenvironment that is characteristic of GBM. Monocytic myeloid-derived suppressor cells are chief immune suppressive cells found in the glioma microenvironment. Understanding the mechanisms of M-MDSC differentiation and T-cell suppression is imperative for generating therapies that target this tumor-supportive cell population. In this study, we found that glioma-secreted CSF1R ligands, M-CSF and IL-34, promote M-MDSCs to suppress CD8 T cells. These M-MDSCs partially utilize nitric oxide synthase to illicit their suppressive activity. However, spatial RNAseq points to glioma microenvironment niches driving M-MDSC heterogeneity. Our findings identify key regulators of differentiation and suppressive mechanisms of M-MDSCs and confirm the importance of targeting this cell population in glioma. Glioblastoma (GBM) is the most common malignant primary brain tumor, resulting in poor survival despite aggressive therapies. GBM is characterized by a highly heterogeneous and immunosuppressive tumor microenvironment (TME) made up predominantly of infiltrating peripheral immune cells. One significant immune cell type that contributes to glioma immune evasion is a population of immunosuppressive cells, termed myeloid-derived suppressor cells (MDSCs). Previous studies suggest that a subset of myeloid cells, expressing monocytic (M)-MDSC markers and dual expression of chemokine receptors CCR2 and CX3CR1, utilize CCR2 to infiltrate the TME. This study evaluated the mechanism of CCR2<superscript>+</superscript>/CX3CR1<superscript>+</superscript> M-MDSC differentiation and T cell suppressive function in murine glioma models. We determined that bone marrow-derived CCR2<superscript>+</superscript>/CX3CR1<superscript>+</superscript> cells adopt an immune suppressive cell phenotype when cultured with glioma-derived factors. Glioma-secreted CSF1R ligands M-CSF and IL-34 were identified as key drivers of M-MDSC differentiation while adenosine and iNOS pathways were implicated in the M-MDSC suppression of T cells. Mining a human GBM spatial RNAseq database revealed a variety of different pathways that M-MDSCs utilize to exert their suppressive function that is driven by complex niches within the microenvironment. These data provide a more comprehensive understanding of the mechanism of M-MDSCs in glioblastoma. [ABSTRACT FROM AUTHOR]
- Subjects :
- IMMUNOLOGICAL tolerance
BIOLOGICAL models
FLOW cytometry
LIGANDS (Biochemistry)
T cells
GLIOMAS
RESEARCH funding
T-test (Statistics)
ADENOSINES
ENZYME-linked immunosorbent assay
TUMOR markers
MYELOID-derived suppressor cells
CELLULAR signal transduction
MICE
IMMUNOHISTOCHEMISTRY
CELL culture
CELL lines
GENE expression
ANIMAL experimentation
ONE-way analysis of variance
ANALYSIS of variance
CELL differentiation
NITRIC-oxide synthases
CHEMOKINE receptors
MICROSCOPY
CYTOKINES
DATA analysis software
PHENOTYPES
SEQUENCE analysis
INTERLEUKINS
Subjects
Details
- Language :
- English
- ISSN :
- 20726694
- Volume :
- 16
- Issue :
- 17
- Database :
- Complementary Index
- Journal :
- Cancers
- Publication Type :
- Academic Journal
- Accession number :
- 179645628
- Full Text :
- https://doi.org/10.3390/cancers16173055